Updated:
GMO Payment Gateway
GMO Payment Gateway processes about 20 trillion yen annually as Japan's leading listed payment orchestrator, spanning online, in-store, and BaaS rails.
GMO Payment Gateway
General information
Firm type
Asset Manager
Location
Region
North America
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Additional offices
Kyushu, Japan
Sector focus
Frequently asked questions
What is GMO Payment Gateway's core business model?
GMO Payment Gateway operates as a payment aggregator and processor. It connects merchants to multiple payment methods — credit cards, convenience store payments, digital wallets like PayPay, and carrier billing — through a single integration. The firm earns fees on transaction volume rather than taking credit exposure or holding customer deposits.
Does GMO Payment Gateway operate outside Japan?
The firm states it actively pursues global operations, though its known processing volume disclosures and office network remain focused on Japan, with a Kyushu regional office and headquarters in Tokyo. Specific overseas offices or international processing volumes have not been publicly detailed.
What was the significance of the March 2026 AI documentation release?
In March 2026, GMO Payment Gateway publicly released an LLM-search and AI-supported payment development documentation portal. The firm identifies this as a first among Japanese Payment Service Providers, aimed at accelerating merchant and developer integration with its platform.
Which Japanese financial institutions does GMO Payment Gateway have lending relationships with?
In March 2026, GMO Payment Gateway entered into a Sustainability-Linked Loan agreement with Mizuho Bank and MUFG Bank. The terms of the loan tie interest rate conditions to sustainability performance targets.
What are GMO Payment Gateway's main consolidated subsidiaries?
Key consolidated entities include GMO Epsilon, which provides payment platform services; GMO Enpay, a multi-payment collection solutions provider; and GMO Reserve Plus, fully consolidated as of October 2025. GMO Medical Reservations Technology changed its trade name in February 2025.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: